Literature DB >> 15275304

Plasmodium vivax: Merozoites, invasion of reticulocytes and considerations for malaria vaccine development.

M R Galinski1, J W Barnwell.   

Abstract

Several Plasmodium vivax merozoite proteins have been characterized over the past few years, including two that bind specifically to reticulocytes. Here, Mare Galinski and John Barnwell examine P. vivax merozoites and constituent molecules that are involved in host cell selection and invasion, and that also are viewed as malaria vaccine candidates. They also discuss how knowledge of the reticulocyte-binding proteins furthers the development of a conceptual framework for malaria merozoite invasion at the molecular level, not only for P. vivax, but for all species of the parasite.

Entities:  

Year:  1996        PMID: 15275304     DOI: 10.1016/0169-4758(96)80641-7

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  45 in total

1.  Experimental infection of Anopheles sinensis with Korean isolates of Plasmodium vivax.

Authors:  H W Lee; S H Cho; E H Shin; J S Lee; J S Lee; J Y Chai; S H Lee; T S Kim
Journal:  Korean J Parasitol       Date:  2001-06       Impact factor: 1.341

2.  Proteomic analysis of haptoglobin and amyloid A protein levels in patients with vivax malaria.

Authors:  Young Yil Bahk; Byoung-Kuk Na; Shin-Hyeong Cho; Jung-Yeon Kim; Kook-Jin Lim; Tong-Soo Kim
Journal:  Korean J Parasitol       Date:  2010-09-16       Impact factor: 1.341

Review 3.  Plasmodium vivax malaria: status in the Republic of Korea following reemergence.

Authors:  Jae-Won Park; Gyo Jun; Joon-Sup Yeom
Journal:  Korean J Parasitol       Date:  2009-10       Impact factor: 1.341

4.  Subcellular localization and functional characterization of Nc-p43, a major Neospora caninum tachyzoite surface protein.

Authors:  A Hemphill
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Expression and serologic activity of a soluble recombinant Plasmodium vivax Duffy binding protein.

Authors:  T Fraser; P Michon; J W Barnwell; A R Noe; F Al-Yaman; D C Kaslow; J H Adams
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

6.  ATP/ADP binding to a novel nucleotide binding domain of the reticulocyte-binding protein Py235 of Plasmodium yoelii.

Authors:  Jeya Kumar Ramalingam; Cornelia Hunke; Xiaohong Gao; Gerhard Grüber; Peter Rainer Preiser
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

7.  Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax.

Authors:  Hyeong-Seok Lim; Jeong-Soo Im; Joo-Youn Cho; Kyun-Seop Bae; Terry A Klein; Joon-Sup Yeom; Tae-Seon Kim; Jae-Seon Choi; In-Jin Jang; Jae-Won Park
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

8.  Evaluation of anti-malarial effects of mass chemoprophylaxis in the Republic of Korea army.

Authors:  Joon-Sup Yeom; Seung-Ho Ryu; Sejoong Oh; Dong-Hyun Choi; Kyoung-Jun Song; Young-Ha Oh; Jae-Hyun Lee; Young-A Kim; Sun-Young Ahn; Hwa-Young Yang; Je-Eun Cha; Jae-Won Park
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

9.  Structural determination of functional units of the nucleotide binding domain (NBD94) of the reticulocyte binding protein Py235 of Plasmodium yoelii.

Authors:  Ardina Grüber; Malathy S S Manimekalai; Asha M Balakrishna; Cornelia Hunke; Jeyaraman Jeyakanthan; Peter R Preiser; Gerhard Grüber
Journal:  PLoS One       Date:  2010-02-10       Impact factor: 3.240

Review 10.  Plasmodium vivax: who cares?

Authors:  Mary R Galinski; John W Barnwell
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.